SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Feedback Editors

Spotlight

Galen plans to sell “green whistle” pain drug in UK and Ireland

Galen plans to sell “green whistle” inhalable pain drug in UK and Ireland

Almac’s subsidiary Galen has licensed UK sales and marketing rights to an emergency pain drug nicknamed the...

Trial transparency: NICE stands firm on data

Trial transparency: NICE stands firm on data

The UK’s NICE says it will go over drug companies’ heads and get clinical trial data from...

Mannkind looks to Sanofi for secondary supply of inhalable insulin API

Mannkind looks to Sanofi for secondary supply of inhalable insulin API

Mannkind says Sanofi could become a second API supplier for its recently approved inhalable insulin drug Afrezza...

Drug prices will continue to vary accross Africa says analyst

Drug prices will continue to vary accross Africa says analyst

High importation costs and country-to-country differences in national healthcare systems mean drugmakers will continue to vary the...

Hyperion ends drug candidate truials after discovering fake data

$20m Andromeda strains Hyperion as fake data ends diabetes drug development

Hyperion says it is “shocked and disheartened” after discovering Phase III trial data for a type 1...

ISPE offers preview to drug shortages prevention plan

ISPE offers preview to drug shortages prevention plan

The International Society for Pharmaceutical Engineering (ISPE) last week offered up a preview to its plan to...

Key Industry Events

 

Access all events listing

Our events, Events from partners...